114 related articles for article (PubMed ID: 3142116)
1. A three year follow-up of chemotherapy with praziquantel in a rural Zambian community endemic for schistosomiasis mansoni.
Sukwa TY; Boatin BA; Wurapa FK
Trans R Soc Trop Med Hyg; 1988; 82(2):258-60. PubMed ID: 3142116
[TBL] [Abstract][Full Text] [Related]
2. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.
Sukwa TY; Bulsara MK; Wurapa FK
J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277
[TBL] [Abstract][Full Text] [Related]
3. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
4. A community-based randomized trial of praziquantel to control schistosomiasis morbidity in schoolchildren in Zambia.
Sukwa TY
Ann Trop Med Parasitol; 1993 Apr; 87(2):185-94. PubMed ID: 8561526
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
6. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.
Boisier P; Ramarokoto CE; Ravaoalimalala VE; Rabarijaona L; Serieye J; Roux J; Esterre P
Trans R Soc Trop Med Hyg; 1998; 92(4):451-3. PubMed ID: 9850407
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and intensity of Schistosoma mansoni infection among residents in two Egyptian villages, at two and twelve months post-treatment with 40 and 60 mg praziquantel per kg body weight at these two villages respectively.
Abu-Elyazeed RR; Mansour NS; Campbell JR
J Egypt Soc Parasitol; 1998 Apr; 28(1):9-16. PubMed ID: 9617038
[TBL] [Abstract][Full Text] [Related]
8. Schistosomiasis mansoni in Burundi: progress in its control since 1985.
Engels D; Ndoricimpa J; Gryseels B
Bull World Health Organ; 1993; 71(2):207-14. PubMed ID: 8490984
[TBL] [Abstract][Full Text] [Related]
9. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
Gryseels B; Nkulikyinka L
Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
[TBL] [Abstract][Full Text] [Related]
10. The effect of praziquantel against Schistosoma mansoni-infections in Botswana.
Friis H; Byskov J
Trop Geogr Med; 1989 Jan; 41(1):49-51. PubMed ID: 2503911
[TBL] [Abstract][Full Text] [Related]
11. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
13. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
Barbosa LM; Reis EA; Dos Santos CR; Costa JM; Carmo TM; Aminu PT; Pitanga TN; Ponce-Terashima R; Blank WA; Silva LK; Reis MG; Blanton RE
Int J Parasitol; 2016 May; 46(5-6):343-50. PubMed ID: 26953255
[TBL] [Abstract][Full Text] [Related]
14. The relationship between morbidity and intensity of Schistosoma mansoni infection in a rural Zambian community.
Sukwa TY; Bulsara MK; Wurapa FK
Int J Epidemiol; 1986 Jun; 15(2):248-51. PubMed ID: 3087895
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of mass chemotherapy, transmission and risk factors for Schistosoma mansoni infection in very low endemic communities of Venezuela.
Hofstede SN; Tami A; van Liere GA; Ballén D; Incani RN
Acta Trop; 2014 Dec; 140():68-76. PubMed ID: 25128702
[TBL] [Abstract][Full Text] [Related]
17. Histopathological changes in experimental schistosomiasis mansoni before and after praziquantel therapy.
el-Hawey AM; Hassan I; el-Ibiary S; Massoud AM
J Egypt Soc Parasitol; 1986 Jun; 16(1):117-26. PubMed ID: 3088137
[No Abstract] [Full Text] [Related]
18. Impact of population-based selective chemotherapy on prevalence and intensity of Schistosoma mansoni infections in the Nile Delta: Kafr El Sheikh.
Barakat R; el Masry AG; Farghaly A; el Morshidy HN; elSayed MK; Husein MH; Miller FD
Trop Geogr Med; 1995; 47(6):266-70. PubMed ID: 8650737
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
[TBL] [Abstract][Full Text] [Related]
20. Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni.
Gryseels B; Nkulikyinka L; Engels D
Am J Trop Med Hyg; 1994 Nov; 51(5):634-41. PubMed ID: 7985756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
